In:
ChemMedChem, Wiley, Vol. 4, No. 6 ( 2009-06-08), p. 957-962
Kurzfassung:
We have optimized previously discovered benzoic acids 1 , which are active as inhibitors of PTP1B and LMW‐PTP, two protein tyrosine phosphatases that have emerged as attractive targets for the development of novel therapeutic agents for the treatment of diabetes, obesity, and cancer. Our efforts led to the identification of new and more potent analogues with appreciable selectivity toward human PTP1B and the IF1 isoform of human LMW‐PTP. magnified image
Materialart:
Online-Ressource
ISSN:
1860-7179
,
1860-7187
DOI:
10.1002/cmdc.200800427
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2009
ZDB Id:
2209649-8
SSG:
15,3